Shots:
The US FDA has granted FTD to RNS60 (oxygen-enriched saline) for the treatment of acute ischemic stroke
Designation was based on extensive preclinical data & P-II (RESCUE) trial, which showed reduced brain tissue loss, improved functional outcomes, & shorter hospital stays in pts treated within 24 hours of stroke onset
Additionally, Revalesio is planning…
